Clinical Trial Update: Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effectiveness of TOBRACORT versus TOBRADEX for reducing the signs and symptoms of acute bacterial conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• TOBRACORT (tobramycin/dexamethasone)
• Tobradex (tobramycin and dexamethasone)

Snippet

Sponsor: Azidus Brasil | Conditions: Acute Bacterial Conjunctivitis | Phase 3 | Status: UNKNOWN